← FDA Drug Approvals (Drugs@FDA)
ACETAMINOPHEN AND IBUPROFEN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2024-04-26
Drug application
- FDA Application #
ANDA218311- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ACETAMINOPHEN AND IBUPROFEN
- Generic name
- ACETAMINOPHEN, IBUPROFEN
- Active ingredients
- ACETAMINOPHEN; IBUPROFEN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Over-the-counter
- Sponsor
- GLENMARK PHARMS LTD
- Manufacturer
- GLENMARK THERAPEUTICS INC., USA
- First approval
- 2024-04-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown